Proteins and peptides bound to long-circulating liposomes

Area of Science:

• Biotechnology
• Pharmaceutics
• Drug Delivery Systems

Background:

• Liposomes are investigated for sustained drug release.
• Prolonging the circulation time of therapeutic proteins and peptides is a challenge in drug delivery.

Purpose of the Study:

• To evaluate liposome formulations for prolonging the circulation time of surface-conjugated proteins and peptides.
• To assess the impact of formulation parameters on circulation half-life and biological activity.

Main Methods:

• Conjugating proteins (asialofetuin, ricin A-chain) and a peptide (yeast a-factor) to the surface of liposomes.
• Varying liposome size, lipid composition, and protein/lipid ratio.
• Measuring circulation half-life and assessing biological activity preservation.

Main Results:

• Circulation half-life increased 2- to 150-fold depending on formulation parameters.
• Surface conjugation maintained direct receptor binding availability and biological activity.
• Successful application to asialofetuin, ricin A-chain, and yeast a-factor.

Conclusions:

• Liposome surface conjugation is an effective strategy to prolong protein and peptide circulation time.
• This approach preserves the biological activity of conjugated molecules.
• Liposomal formulations offer a promising sustained-release drug delivery system for proteins and peptides.